Advances in the treatment of chronic atrophic gastritis with a combination of Chinese and Western medicine and the public health implications

Mingyi Ma; Jingjing Qi; Rongqin Jiang

doi:10.54097/hset.v6i.1033

Authors

Mingyi Ma
Jingjing Qi
Rongqin Jiang

DOI:

https://doi.org/10.54097/hset.v6i.1033

Keywords:

chronic atrophic gastritis, Chinese medicine, Western medicine, combined Western and Chinese medicine, public health.

Abstract

Chronic atrophic gastritis (CAG) is a disease characterized by atrophy of the gastric mucosa and reduction of intrinsic glands, accompanied by intestinal hyperplasia and/or pseudopyloric glandular hyperplasia, and is a common clinical gastrointestinal lesion that can be produced by the interaction of multiple factors. The pathogenesis of CAG has not been completely clarified, and there are no specific drugs or treatment methods, and the disease is prone to recurrence. The pathogenesis of CAG is not fully understood, and there is no specific drug or treatment, and the disease is prone to recurrence. This paper reviews the treatment progress and public health implications of Western medicine, Chinese medicine, and the combination of Western and Chinese medicine in the treatment of chronic atrophic gastritis, in order to provide some reference for the clinical treatment and public prevention of chronic atrophic gastritis.

Downloads

Download data is not yet available.

References

Xu WC,Xu Yl,Zhang ZB,et al. A study on the pattern of medication for chronic atrophic gastritis in Beijing-Tianjin-Hebei region based on the hidden structure model of evidence-based treatment by famous old Chinese medicine experts[J]. Chinese Journal of Traditional Chinese Medicine,2020(7):1691-1697.

Deng DH, Huang ZB, Zhou H. Clinical efficacy of Tiao Zhong Yi Qi Tang plus and minus combined with recruitment and matching point moxibustion in the treatment of chronic atrophic gastritis with evidence of spleen and stomach weakness [J]. Sichuan Traditional Chinese Medicine, 2021, 39(5): 99-101.

Chinese Society of Traditional Chinese Medicine, Branch of Spleen and Stomach Diseases. Consensus opinion on Chinese medicine treatment of chronic atrophic gastritis (Shenzhen, 2009) [J]. Chinese Journal of Integrative Medicine and Digestion, 2010, 18(5):345-349.

Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interob server consistency using new criteria for classification and grading [J]. Aliment Pharmacol Ther, 2002, 1 6(7):1 249-1 259.

Chinese Medical Association, Gastroenterology Branch . Consensus opinion on chronic gastritis in China (2017, Shanghai) [J]. Chinese Journal of Gastroenterology, 2017, 37(11):721-738.

Zhang SS., Tang XD., Huang SP., et al. Expert consensus opinion on the diagnosis and treatment of chronic gastritis in Chinese medicine (2017) [J]. Chinese Journal of Traditional Chinese Medicine, 2017, 32(7): 3060-3064.

Zhao XL, Cheng RD, Zhao B, et al. Comparative analysis of Chinese medical treatment consensus in chronic atrophic gastritis[J]. Chinese Journal of Traditional Chinese Medicine,2018, 33(09):106-108.

You SW, Zhan YM, Yi X, et al . Exploration of the prescription mechanism of the Miao medicine group formula Wei Wei Tong Tiao Tang in the treatment of chronic atrophic gastritis [J]. Journal of Gui zhou University of Traditional Chinese Medicine, 2020, 42(1): 58-60.

Chen ZD, Chen H. Efficacy of Huang Lian Su combined with Teprenone in the treatment of chronic atrophic gastritis [J]. Inner Mongolia Traditional Chinese Medicine, 2020, 39(1):1-3.

Chen XW . Clinical observation on the treatment of chronic atrophic gastritis (liver and stomach qi stagnation type) with Chai Hu Shu Liver San combined with Han Xia Di Xin Tang [J]. Guangming TCM, 2020, 35(2): 213-215.

Qiu B, Zhang SB, Tian HX with the combination of Hepatococcus pylori decoction and Chai Hu Shu Hepatococcus addition [J]. Hebei Traditional Chinese Medicine, 2019, 41(12): 1827-1830.

Yang Y, Wang BX, Ren QH. Clinical study on the treatment of chronic atrophic gastritis with Xiang Sha Yang Gastric Pill combined with Teprenone capsule [J]. Modern Drugs and Clinics,2017,32(1):71- 75.

Fang F, Li XL. Changes in erythrocyte immune function before and after Helicobacter pylori eradication therapy in patients with chronic atrophic gastritis[J]. Journal of Clinical Gastroenterology,2021,33(2):83- 86.

You WC, Brown LM, Zhang L, et a1. Randomized double blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions [II. J NATL CANCER I, 2006, 98(14): 974-983.

Shu X, Lu NH, Zhu Y, et al. Eradication of Helicobacter pylori on gastric sinus mucosal atrophy and intestinal epithelial hyperplasia [J] Chinese Journal of Gastroenterology, 2009, 29(12): 799-802.

Rezaei Tavirani M, Rezaei Tavirani S, Tajik Rostami F. Biochemical pathway analysis of gastric atrophy [J]. Gastroenterol Hepatol Bed Bench,2018,11(2):118-124.

Liu HL, Luo Yan, Zou MY, et al. A pilot study on the application of photodynamic therapy for Helicobacter pylori-associated gastritis [J]. Journal of Practical Medicine, 2011, 27(22):4028- 4030.

Mallik R, Manocha A, Suresh D K. Photodynamic therapy strategic review[J].Indian J Dent Res, 2012, 2 1(2):285-291.

Chinese Medical Association, Gastroenterology Branch. The consensus opinion on some issues of Helicobacter pylori (2003 China). Chinese Medical Journal, 2004, 84(6):522--523.

Yang Q. Clinical study on the combined application of amoxicillin and lansoprazole in the treatment of chronic atrophic gastritis [J]. Gansu Science and Technology,2016,32(5):104-105.

Liao LILI, Yang BAIJING. Clinical efficacy of combined traditional Chinese and Western medicine in the treatment of chronic atrophic gastritis combined with Helicobacter pylori infection [J]. Chongqing Medicine,2017,46(29): 4164-4165,4168.

Gan J, Cheng RG, Wang SF. Diagnostic value of serum pepsinogen for gastric diseases[J]. World Journal of Chinese Digestion,2018,26(36):2115-2119.

Wu Z. Clinical study on the treatment of chronic atrophic gastritis with anxiety and depression by combining Ginseng Qi Stomach Granules combined with Liver Relief Capsules [J]. China Pharmaceutical,2017,26(20):66-69.

Liu ZB. Clinical study of combined multiple drugs for the comprehensive treatment of chronic atrophic gastritis [J]. Gansu Science and Technology,2016,32(6):116-118.

Wang XP, Xu YH. Study on the effect of amoxicillin combined with bismuth on serum gastrin-17 and pepsinogen levels in patients with chronic atrophic gastritis[J]. Chinese Journal of Biochemical Drugs,2016,36(3):64-66

Gao FG. A book of 108 cases of chronic atrophic gastritis treated with Chinese medicine evidence. Medical Theory and Practice, 2004, 17(8):908-909.

Wang SL, Lu XX, Ma X, et al. Clinical efficacy of flavopiridol in the treatment of chronic atrophic gastritis and the effects on serum VEGF, PG Ⅰ and PG Ⅱ levels in patients[J]. Modern Biomedical Progress,2018,18(1):100-103,129.

Liu SL, Su R, Zhang L, et al. Intervention study on the pathology of intestinal chemosis and Caspase-3 expression in chronic atrophic gastritis with weak spleen and stomach with Ginseng-Qi Drink [J]. Chinese Journal of Integrative Medicine and Digestion, 2011, 19(3): 168-169.

Yu XC. A randomized parallel controlled study on the treatment of chronic atrophic gastritis by combining Western medicine with evidence-based typing[J]. Journal of practical Chinese medicine internal medicine,2017,31(2):34-36.

Chen B. Treatment of atrophic gastritis with specific prescriptions of traditional Chinese medicine [J]. Journal of Guangxi University (Natural Science Edition), 1998(2):196-199.

PIMENTEL-NUNES P, LIBANIO D, MARC0s. PINT0 R, et a1. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II). european society of gas- trointestinal end' oscopy (ESGE), european helicobacter and microbiota study group (EHMSG), european society of pa- thology (ESP), and sociedade portuguesa de endoscopia digestiva (SPED) guideline update 2019FJ].Endoscopy, 2019,. 51(4):365-388.

Lu L, Jin JJ, Xing RQ, Efficacy of WeiFuChun in the treatment of gastric precancerous lesions[J].I Clinical Medicine, 2010, 28(2): 86-88.

Zhou Y. Efficacy analysis of 80 cases of chronic atrophic gastritis treated with Yogastric Shu capsule [J]. Contemporary medicine, 2014, 20(16): 137.

Wang QH, Tang MW, YN et al. The efficacy of Qifang Gastroparesis Granules on 42 cases of spleen deficiency type atrophic gastritis [J]. Modern Digestion and Interventional Therapy, 2012, 17(2): 104-106.

Wang L, REN XY, MU HX, et al. Clinical study on the treatment of precancerous lesions in chronic atrophic gastritis with the formula of detoxification of turbidity [J]. Chinese medicine information,2017,34(1):99-100.

Fan LH, Fang Y, Huang H, et al. A multicenter prospective clinical study of acupuncture and moxibustion for the treatment of chronic atrophic gastritis [J]. Journal of Hunan University of Traditional Chinese Medicine, 2020, 40 (9): 1060-1064.

Gu W. Hu QC. Comparative observation of the efficacy of acupuncture in the treatment of chronic atrophic gastritis [J]. Chinese Acupuncture, 2009, 29(5): 361-364

Xiao GR, Wang KY. Observation on the efficacy of JianPiTongluo Tang in treating chronic atrophic gastritis [J]. Shaanxi Traditional Chinese Medicine,2017,38(1):45-46.

Li HJ. Analysis of the efficacy of gastric rehabilitation and acupuncture point burial method in treating 120 cases of chronic atrophic gastritis [J]. Medical Theory and Practice, 2005, 18(1):49-50.

Zhou W, Yang Q, Shu WN, et al. Effects of moxibustion and acupuncture on apoptosis and NF-*B and Bcl-2 gene expression in gastric mucosa of rats with chronic atrophic gastritis [J]. Acupuncture Research, 2021, 46(4): 284-288.

Lin H, Cao DQ, Yue RF. The efficacy of triple therapy to eradicate Helicobacter pylori combined with gastric rejuvenation in the treatment of chronic atrophic gastritis. Ganan Medical Journal, 2010, 30 (1): 48-49.

Li D, Wang R, Yu YQ, et al. Rabeprazole, amoxicillin, and clarithromycin combined with Hovenia Kuanzhong capsule for the treatment of Helicobacter pylori-positive chronic atrophic gastritis in the elderly [J]. Shandong Medicine,2018,58(3):78-80.

Zhao L, Dai EQ. Two examples of experience with Chai Hu plus Long Bone Oyster Soup in the treatment of chronic atrophic gastritis combined with insomnia[J]. Global Chinese Medicine,2018,11(8):1305-1306.

Zhuang YY, Rao ZL, Fang TY, et al. Clinical study on the treatment of chronic atrophic gastritis with Rebapite tablets combined with rabeprazole sodium enteric solution tablets[J]. Chinese Journal of Clinical Pharmacology,2018,34(19):2273-2275.

SIPPONEN P, MAAROOS H I. Chronic gastritis [J]. Scand J Gastroenterol , 2015, 50(6):657-667.

WANG YJ, GUO S, YANG Y, et al. Epidemiology of chronic atrophic gastritis and analysis of its risk factors [J]. Chinese Journal of Integrative Medicine and Gastroenterology, 2019, 27(II): 874-878.

Fang JY, Du YQ, Liu WZ, et al. Consensus opinion on chronic gastritis in China (Shanghai, 2017) [J]. Gastroenterology, 2017, 22(11): 670-687.

CORREA P. Human gastric carcinogenesis: a muhistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention[J].Cancer Res, 1992, 52(24):6735-6740.

DE VRIES A C, VAN GRIEKEN N C, L00MAN C W, et a1. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands[J]. Gastroenterology, 2008, 134(4):945-952.